Penn’s ITMAT symposium addresses topics of direct relevance to translational science

NewsGuard 100/100 Score

The Institute for Translational Medicine and Therapeutics' 7th Annual International Symposium (ITMAT) symposium, Harnessing the Paradox: Personalization and the Science of Scale, to be held in October 2013, will address topics of direct relevance to translational science. ITMAT is part of the Perelman School of Medicine at the University of Pennsylvania.

Speakers will include those dealing with large infrastructural investments, such as the recently funded $1 Billion European brain mapping program, as well as broad areas of scientific advancement such as systems biology, optogenetics and lab-on-a-chip technologies and specific advances in metabolism, metabolomics and the microbiome.

Garret A. FitzGerald, Director of ITMAT, will be hosting the event. The speakers and talks include:

 

  • Leroy Hood, MD, PhD, President, Institute for Systems Biology Systems Medicine, Transformational Technologies and the Emergence of Proactive P4 Medicine (Predictive, Preventive, Personalized and Participatory)

     

     

  • Sir Rory Collins, FMed Sci, FRCP, Professor of Medicine and Epidemiology, Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford UK Biobank: An Open Access Resource for Health Research

     

     

  • Frederic Bushman, PhD, Professor of Microbiology, Perelman School of Medicine at the University of Pennsylvania The Human Microbiome in Health and Disease

     

     

  • Jayne Danska, PhD, Senior Scientist, Program in Genetics and Genome Biology, the Hospital for Sick Children, Professor, Department of Immunology and Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Canada The Architecture of Complex Disease: Genes, Sex, Bugs and Diabetes

     

     

  • Chi Van Dang, MD, PhD, Director, Abramson Cancer Center, John H. Glick, MD Abramson Cancer Center Director's Professor, Perelman School of Medicine at the University of Pennsylvania Targeting Cancer Metabolism

     

     

  • Shoukhrat Mitalipov, PhD, Oregon National Primate Research Center, Oregon Health & Science University Reproductive and Reprogramming Approaches for Treatment of mtDNA Disease

     

     

  • Richard Frackowiak, MA, MD, DSc, Professor, Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland The Human Brain Project: from Phenomena to Biology

The dinner speaker will be Chris Austin, MD, Director of National Center for Advancing Translational Sciences.

Source: University of Pennsylvania School of Medicine

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative breast cancer treatment sequence yields positive results